Immunic | VTL - Interest Expense On Debt


Immunic reported 400K in Interest Expense on Debt for its fiscal quarter ending in December of 2024.





Interest Expense On Debt Change Date
BioMarin Pharmaceutical USD 2.78M 199K Dec/2025
Cipla INR 140.3M 8.5M Dec/2025
Compugen USD 954K 116K Sep/2025
CSL USD 215M 111M Dec/2025
Enanta Pharmaceuticals USD 1.96M 620K Dec/2024
Grifols EUR 156.07M 31.46M Sep/2025
Immunic 400K 400K Dec/2024
Insmed USD 20.6M 217K Dec/2025
Omeros USD 4.05M 5.16M Sep/2024
OraSure Technologies 1.67M 1.13M Dec/2025
Quidel USD 5.68B 5.63B Sep/2025
Ultragenyx Pharmaceutical USD 19M 4.85M Dec/2025
United Therapeutics USD 3.1M 100K Dec/2025
Xoma USD 3.4M 150K Jun/2024